You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

About Triumeq

The first single-pill regimen built with dolutegravir.
Learn more about prescribing TRIUMEQ, including dosing instructions, safety & tolerability, and drug-drug interactions.

Find out more

Video player requires JavaScript enabled. You can download this video here: http://edgesuite.gskstatic.com/HealthSites/Health/Singapore/MP4/H3OnDolutegravir.mp4

Learn about antiretroviral therapy in HIV-1-infected adults and adolescents

Triumeq is a registered trademark of the GlaxoSmithKline group of companies.

All images are for illustration purposes only.